Dulcolax and Coq10 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dulcolax (bisacodyl) and Coq10 (coenzyme q - 10). Common drug interactions include alopecia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Dulcolax and Coq10. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Coq10?

Coq10 has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 10,401 Coq10 users. Check the latest studies of Coq10.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

37 people who take Dulcolax and Coq10 together, and have interactions are studied.

What are the common drug interactions of Dulcolax and Coq10, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Feeling cold
Groin pain
Hair colour changes
Hair disorder
Loss of consciousness
Malaise (a feeling of general discomfort or uneasiness)
Mitral valve incompetence (inefficient heart valve)
Muscle rigidity (muscle stiffness)

male:

Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Muscular weakness (muscle weakness)
Neuropathy peripheral (surface nerve damage)
Skin cancer
Abdominal discomfort
Anaemia (lack of blood)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Decreased interest

What are the common drug interactions of Dulcolax and Coq10, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Altered state of consciousness (altered state of mind)
Dysarthria (speech disorder)
Dyspnoea (difficult or laboured respiration)
Fall
Muscular weakness (muscle weakness)
Nausea (feeling of having an urge to vomit)
Paralysis

50-59:

Angina pectoris (chest pain due to ischemia of the heart muscle)
Mitral valve incompetence (inefficient heart valve)
Tricuspid valve incompetence (inefficient heart valve)
Death
Muscle atrophy (a decrease in the mass of the muscle)
Neoplasm progression (growth of tumour)

60+:

Fatigue (feeling of tiredness)
Alopecia (absence of hair from areas of the body)
Hair disorder
Hemiparesis (weakness on one side of the body)
Hyperglycaemia (high blood sugar)
Insomnia (sleeplessness)
Loss of consciousness
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Muscle rigidity (muscle stiffness)
Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

Hyperkalemia (damage to or disease of the kidney): 3 people, 8.11%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 8.11%
Weight Loss: 2 people, 5.41%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.41%
Renal Cell Carcinoma (a kidney cancer): 2 people, 5.41%
Prostatic Disorder: 2 people, 5.41%
Perennial Allergy (airborne allergy): 2 people, 5.41%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.41%
Multiple Myeloma (cancer of the plasma cells): 2 people, 5.41%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and Coq10?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously